New Study Published In Molecular Medicine Reports That Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes

New Study Published In Molecular Medicine Reports That Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes